The i on MSN9 時間
‘Game-changing’ chronic and recurrent UTI drug to be rolled out across NHS in weeks
Game-changer' drug Hiprex is set to be approved for NHS use - but there is still no official guidance for treating chronic ...
ENHERTU® Receives Prestigious 2024 Prix Galien USA Award for Best Biotechnology Product
ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca.